Page last updated: 2024-11-02

pd 98059 and Proliferative Vitreoretinopathy

pd 98059 has been researched along with Proliferative Vitreoretinopathy in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weng, CY1
Kothary, PC1
Verkade, AJ1
Reed, DM1
Del Monte, MA1
Bando, H1
Ikuno, Y1
Hori, Y1
Sayanagi, K1
Tano, Y1

Other Studies

2 other studies available for pd 98059 and Proliferative Vitreoretinopathy

ArticleYear
MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE).
    Current eye research, 2009, Volume: 34, Issue:10

    Topics: Cell Culture Techniques; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Extrac

2009
Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction.
    Experimental eye research, 2006, Volume: 82, Issue:3

    Topics: Androstadienes; Cell Line; Collagen; Enzyme Inhibitors; Extracellular Matrix; Flavonoids; Flow Cytom

2006